. /.   WORLD TRADE  
ORGANIZATION  G/TBT/N/NIC/107 
7 May 2009 
 (09-2241) 
Committee on Technical Barriers to Trade Original:   Spanish 
  
 
NOTIFICATION 
 
The following notification is being circ ulated in accordance with Article 10.6. 
 
1. Member to Agreement notifying:  NICARAGUA
 
If applicable, name of local government involved (Articles 3.2 and 7.2):    
2. Agency responsible:   Ministerio de Fomento, Industria y Comercio  (Ministry of 
Development, Industry and Trade) 
Name and address (including telephone and fax numbers and E-mail and website 
addresses, if available) of  agency or authority designated to handle comments 
regarding the notification shall be  indicated if different from above:    
Ministerio de Salud  (Ministry of Health) 
División de Farmacia  (Pharmacy Division) 
Telefax: +(505) 2289-4401 E-mail: div-far@minsa.gob.ni 
3. Notified under Article 2.9.2 [  X ], 2.10.1 [   ], 5.6.2 [   ], 5.7.1 [   ], other:    
4. Products covered (HS or CCCN where applicable, otherwise national tariff heading.
ICS numbers may be provided in addition, where applicable):   International 
Classification for Standards (ICS) code 11.120.99 
5. Title, number of pages and language(s) of the notified document:   NTON 19 007-09 / 
RTCA 11.03.56:09, Productos Farmacéuticos. Productos Naturales Medicinales para Uso 
Humano. Verificación de la Calidad   (Nicaraguan Mandatory Technical Standard (NTON) 
No. 19 007-09 / Central American Techni cal Regulation (RTCA) No. 11.03.56:09: 
Pharmaceutical products.  Natura l medicines for human use.  Quality control) (8 pages, in 
Spanish). 
6. Description of content:   The notified Technical Regulation establishes the analytical tests 
which must be carried out by the regulatory authority to verify the quality of natural medicines for human use. 
 
The provisions of this Regulation apply to all natural medicines for human use which are imported into or manufactured in Central American countries.   The Regulation guidelines are mandatory for al l natural medicines the pharmaceutical form 
of which is administered by any route other than ophthalmic or parenteral. 
7. Objective and rationale, including the na ture of urgent problems where applicable:  
Prevention of practices likely to mislead the consumer and protection of human health. G/TBT/N/NIC/107 
Page 2  
 
  8. Relevant documents:    
• Appendix XVI D, Microbiological quality of pharmaceutical preparations , British 
Pharmacopoeia, Volume IV. 2007. 
• The United States Pharmacopeia 30 and The National Formulary 25. 30th Edition.  The 
United States Pharmacopeial Convention Inc. USA. 2007. 
• Secretaría de Salud, Comisión Permanente de  la Farmacopea de los Estados Unidos 
Mexicanos  (Ministry of Health, Permanent Pharmacopoeia Commission of the 
United Mexican States), Farmacopea Herbolaria de los Estados Unidos Mexicanos  
(Herbal Pharmacopoeia of the Unite d Mexican States).  Mexico. 2001. 
• Arias, Tomas D., Glosario de Medicamentos: Desarrollo, Evaluación y Uso  (Glossary 
of medicines:  development, evaluation and use), 1
st Edition. Pan American Health 
Organization, USA. 1999. 
• García G., Mildred, Legislación en Iberoamérica sobre Fitofármacos y Productos 
Naturales  (Ibero-American legislation on phytom edicines and natural products).  Ibero-
American Programme of Science and Technology for Development (CYTED). 
Costa Rica, 2000. 
• RTCA 67.04.50:08, Alimentos. Criterios Microbiológicos para la Inocuidad de 
Alimentos  (Central American Technical Regula tion (RTCA) No. 67.04.50:08:  Food 
products.  Microbiological criteria for food safety).  
9. Proposed date of adoption:   
Proposed date of entry into force:    Upon publication in the Official Journal 
To be determined 
10. Final date for comments:   60 days as from the date of notification 
11. Texts available from:  National enquiry point [  X ] or address, telephone and fax 
numbers and E-mail and website addresses, if available, of other body:    
WTO TBT Enquiry Point 
Managua, Nicaragua  Tel.: (505) 2267-4551, ext. 1209, 1230 or 1276 Fax: (505) 2267-4551, ext. 1228  
E-mail: dtnm@mific.gob.ni;  imartinez@mific.gob.ni  
Website: http://www.mific.gob.ni